These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33217512)

  • 21. Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Alfandari S; Gois J; Delannoy PY; Georges H; Boussekey N; Chiche A; Meybeck A; Patoz P; Blondiaux N; Senneville E; Melliez H; Leroy O
    Med Mal Infect; 2014 May; 44(5):229-31. PubMed ID: 24840286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
    Wroblewska MM; Towner KJ; Marchel H; Luczak M
    Clin Microbiol Infect; 2007 May; 13(5):490-6. PubMed ID: 17331123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia.
    D'Onofrio V; Conzemius R; Varda-Brkić D; Bogdan M; Grisold A; Gyssens IC; Bedenić B; Barišić I
    Infect Genet Evol; 2020 Jul; 81():104263. PubMed ID: 32105865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemic Dissemination of a Carbapenem-Resistant Acinetobacter baumannii Clone Carrying armA Two Years After Its First Isolation in an Italian Hospital.
    Milan A; Furlanis L; Cian F; Bressan R; Luzzati R; Lagatolla C; Deiana ML; Knezevich A; Tonin E; Dolzani L
    Microb Drug Resist; 2016 Dec; 22(8):668-674. PubMed ID: 26990617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015).
    Karampatakis T; Antachopoulos C; Tsakris A; Roilides E
    Future Microbiol; 2017 Jul; 12():801-815. PubMed ID: 28604100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clinical and sewage isolates of Acinetobacter baumannii from two long-term care facilities in Zagreb; mechanisms and routes of spread.
    Bedenić B; Siroglavić M; Slade M; Šijak D; Dekić S; Musić MŠ; Godan-Hauptman A; Hrenović J
    Arch Microbiol; 2020 Mar; 202(2):361-368. PubMed ID: 31667533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Containment of a carbapenem-resistant Acinetobacter baumannii complex outbreak in a COVID-19 intensive care unit.
    Eckardt P; Canavan K; Guran R; George E; Miller N; Avendano DH; Kim M; Himed K; Ramirez KHG
    Am J Infect Control; 2022 May; 50(5):477-481. PubMed ID: 35227793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High lethality rate of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units of a Brazilian hospital: An epidemiologic surveillance study.
    Kurihara MNL; Sales RO; Silva KED; Silva GD; Mansano MCT; Mahmoud FF; Simionatto S
    Rev Soc Bras Med Trop; 2022; 55():e05292021. PubMed ID: 35522809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey.
    Kulah C; Mooij MJ; Comert F; Aktas E; Celebi G; Ozlu N; Rijnsburger MC; Savelkoul PH
    Int J Antimicrob Agents; 2010 Aug; 36(2):114-8. PubMed ID: 20510587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program.
    Choi WS; Kim SH; Jeon EG; Son MH; Yoon YK; Kim JY; Kim MJ; Sohn JW; Kim MJ; Park DW
    J Korean Med Sci; 2010 Jul; 25(7):999-1004. PubMed ID: 20592889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.
    Tsiatsiou O; Iosifidis Ε; Katragkou A; Dimou V; Sarafidis K; Karampatakis T; Antachopoulos C; Orfanou A; Tsakris A; Drossou-Agakidou V; Roilides E
    Eur J Pediatr; 2015 Jan; 174(1):65-74. PubMed ID: 24985124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The origin of Acinetobacter baumannii TYTH-1: a comparative genomics study.
    Liu CC; Tang CY; Kuo HY; Lu CW; Chang KC; Liou ML
    Int J Antimicrob Agents; 2013 Apr; 41(4):318-24. PubMed ID: 23402702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbapenem-resistant Acinetobacter baumannii isolates carrying bla
    Yazdansetad S; Najari E; Ghaemi EA; Javid N; Hashemi A; Ardebili A
    J Glob Antimicrob Resist; 2019 Sep; 18():95-99. PubMed ID: 30763760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.
    Héritier C; Dubouix A; Poirel L; Marty N; Nordmann P
    J Antimicrob Chemother; 2005 Jan; 55(1):115-8. PubMed ID: 15590718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence and spread of a multidrug-resistant Acinetobacter baumannii clone producing both the carbapenemase OXA-23 and the 16S rRNA methylase ArmA.
    Brigante G; Migliavacca R; Bramati S; Motta E; Nucleo E; Manenti M; Migliorino G; Pagani L; Luzzaro F; Viganò FE
    J Med Microbiol; 2012 May; 61(Pt 5):653-661. PubMed ID: 22282459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of a hospital-wide outbreak of carbapenem-resistant
    Alon D; Mudrik H; Chowers M; Shitrit P
    Infect Control Hosp Epidemiol; 2020 Aug; 41(8):926-930. PubMed ID: 32539881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
    Jiang W; Liu H; Zhong M; Yang YC; Xiao DW; Huang WF
    Microb Drug Resist; 2013 Apr; 19(2):117-23. PubMed ID: 22845773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wall painting following terminal cleaning with a chlorine solution as part of an intervention to control an outbreak of carbapenem-resistant Acinetobacter baumannii in a neurosurgical intensive care unit in Israel.
    Dickstein Y; Eluk O; Warman S; Aboalheja W; Alon T; Firan I; Putler RKB; Hussein K
    J Infect Chemother; 2021 Oct; 27(10):1423-1428. PubMed ID: 34083145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.
    Bogaerts P; Naas T; Wybo I; Bauraing C; Soetens O; Piérard D; Nordmann P; Glupczynski Y
    J Clin Microbiol; 2006 Nov; 44(11):4189-92. PubMed ID: 16957031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.
    Zander E; Chmielarczyk A; Heczko P; Seifert H; Higgins PG
    J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.